Trial intelligence / Profile preview

Buspirone and Trazodone for Sleep Disordered Breathing in SCI

NCT02458469Phase 2Completed

Sponsor
VA Office of Research & Development
Start
May 2015
Primary completion
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of buspirone, trazodone in sleep disordered breathing (SDB), sponsored by VA Office of Research & Development. Started May 2015; status: completed.

02

Drugs

buspironetrazodone
03

Conditions

sleep disordered breathing (SDB)

Beyond the preview

Go deeper on NCT02458469.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02458469.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call